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a b s t r a c t
Bis-triphenylphosphano-copper(I)-butyrate (C3H7COOCu(PPh3)2) was applied for the synthesis of O-per-
acylated 1-glycopyranosyl-4-substituted-1,2,3-triazoles from the corresponding glycosyl azides and
alkynes. This catalyst proved superior to the CuSO4/L-ascorbic acid system even with sterically hindered
and less reactive glycosyl azides.
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The regioselective formation of 1,4-disubstituted-1,2,3-tria
zoles by Cu(I) catalysed azide–alkyne cycloaddition (CuAAC) is
reliable and robust transformation characterized by high func
tional group tolerance and simple work-up.1 The widespread us
of this reaction is, among others, also related to the increasin
interest in the 1,2,3-triazole ring as a pharmacophore.2 The wid
variety of conditions used to perform CuAAC include numerou
Cu(I) sources such as inorganic salts of copper(I) in the presenc
of a base and/or a ligand stabilizing the Cu(I) oxidation stat
Cu(I) complexes or Cu(II) salts coupled with reducing agents
Development of CuAAC generated remarkable attention in the ﬁel
of carbohydrate chemistry, as well. Synthesis as well as applicatio
of 1,2,3-triazole containing simple glycosides, oligosaccharide
glycomacrocycles, glycoclusters, glycodendrimers, glycopeptide
glycoarrays, glycopolimers and glycosylated biomolecules wer
surveyed in several reviews.3–6
1-Glycosyl-1,2,3-triazole derivatives were obtained from rela
tively easily available glycosyl azides by using diverse Cu(I) source
In situ reduction of Cu(II) salts, usually CuSO4 or Cu(OAc)2 by Na
ascorbate or L-ascorbic acid7–16 as well as by Cu turnings11,17
one of the most commonly used possibilities for the catalysi
whereby, with unprotected glycosyl azides, addition of o-pheny
enediamine18 proved advantageous. CuI is another often applie
0008-6215/$ - see front matter  2012 Elsevier Ltd. All rights reserved.
doi:10.1016/j.carres.2012.01.004
⇑ Corresponding author. Tel.: +36 52 512 900/22348; fax: +36 52 512 744.
E-mail address: somsak@tigris.unideb.hu (L. Somsák).Please cite this article in press as: Bokor, É.; et al. Carbohydr. Res. (20catalyst in the presence of either DIPEA or Et3N with TBTA (N,N,N
tris-[(1-benzyl-1H-1,2,3-triazole-4-yl)methy]amine).19,20 In add
tion, phosphorous containing copper complexes such as (EtO)3P
CuI21 and CuBr(PPh3)322,23 proved to be also suitable catalysts fo
this purpose.
We have reported on the syntheses of three series of 1-(D-gluco
pyranosyl)-4-substituted-1,2,3-triazoles24 4–6 (Table 1) whic
were tested as inhibitors of glycogen phosphorylase enzyme (GP
a validated molecular target for the treatment of type 2 diabete
Several b-D-glucopyranosyl derivatives (O-deprotected 4) prove
to be lowmicromolar inhibitors of GP. Furthermore, their inhibitio
constants as well as bindingmodes (revealed by X-ray crystallogra
phy) showed a remarkable similarity to those of the correspondin
b-D-glucopyranosylamide type inhibitors,25 thereby providing
new example of the amide-1,2,3-triazole bioisosteric relation
ship,26–28 and a new potential biological application of 1-glycosy
1,2,3-triazoles. Regioselective syntheses of the O-peracylated deriv
atives 4–6were carried out in CuAAC reactions of the correspondin
D-glucopyranosyl azides 1–3 with terminal alkynes in water in th
presence of CuSO4 and L-ascorbic acid (Table 1, conditions i). How
ever, under these conditions the desired triazoles could be obtaine
only in low yields and with incomplete conversions of the startin
materials in several cases. Changing the solvent to aqueous CH3NO
or DMSO, and increasing the catalyst load up to 11 mol % did no
bring about signiﬁcant improvements.24 Recently, bis-tripheny
phosphano-copper(I)-butyrate (C3H7COOCu(PPh3)2) was develope
as a new, highly active catalyst for the CuAAC reaction. By using th
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i24) CuSO4, L-ascorbic acid,a H2O, 70 ºC, 8











































.5 mol % CuSO4, 20 mol % L-ascorbic acid for 4, 7.5 mol % CuSO4, 20 mol % L-ascorbic
Necessary for complete consumption of the starting materials 1–3.
Conversion: 63%.24
Reported yield by a different method: 60%.11
Reported yield by a different method: 63%.11our present work has been to investigate its applicability for the














First, the efﬁciency of C3H7COOCu(PPh3)2 was probed in reac-
ns between peracylated glycopyranosyl azides 1–3 and terminal
ynes a–d bearing free hydroxyl, ester, as well as aromatic groups.
e experiments were performed according to the literature proce-
re29 in dichloromethane at room temperature (Table 1, condi-
ns ii). In the reactions with propargyl alcohol (a) the copper(I)-
tyrate proved to be efﬁcient in 2 and 5 mol % ratio for the synthe-
s of 4a and 5a, respectively, while even 8 mol % of the catalyst was







coides 1 and 2 required 1 mol % catalyst load. Generally, syntheses
compounds 5 required longer reaction time as compared to those
derivatives 4, presumably because of the stericallymore crowded
vironment of the azido group in 2. However, it has to be noted,
at in aqueous medium in the presence of CuSO4/L-ascorbic acid
nditions i) transformation of the O-perbenzoylated (b-D-gluco-
pt-2-ulopyranosylazide)onamide (2) occurred only with ethyl









stinversions were also not complete. Somewhat higher amount
the catalyst and longer reaction time were needed to obtain a-
glucopyranosyl-1,2,3-triazole derivatives 6b,c (2 mol %) and 6d
mol %) from the less reactive azide8,11,24 3. Yields were around
above 90% in almost each case demonstrating the superior per-
rmance of C3H7COOCu(PPh3)2 over the CuSO4/L-ascorbic acid sys-
m (compare yields under headings i and ii in Table 1).
The Cu(I)-butyrate complex was also applied for the syntheses
further O-peracetylated 1-glycopyranosyl-4-substituted-1,2,3-ease cite this article in press as: Bokor, É.; et al. Carbohydr. Res. (2012), dazoles from the corresponding glycosyl azides 7–13 (Table 2).
r the formation of b-D-xylopyranosyl- and 20-acetamido-20-
oxy-b-D-glucopyranosyl-1,2,3-triazoles 14 and 15 1 mol % of
e catalyst was as effective as in the b-D-glucopyranosyl series
In a similar manner, reaction of 2-deoxy-2-phtalimido-b-D-glu-
pyranosyl azide 9with phenylacetylene worked well in the pres-
ce of 1 mol % catalyst to give 16d in excellent yield, while
cloaddition with the bulky 2-ethynylnaphtalene e proceeded
ly with higher catalyst load (2 mol %). Synthesis of (20-deoxy-
phtalimido-a-D-glucopyranosyl)-4-phenyl-1,2,3-triazole 17d
quired higher catalyst concentration and longer reaction time
mpared to its b counterpart 16d, similarly to observations with
b pairs earlier (4 versus 6). The observed differences in the reac-
ity of the anomeric pairs of glycosyl azides are in accord with
erature experiences, and may be explained by the higher steric
ndrance of the azido group in a-position or by the different dipo-
character of the anomeric azides arising from the anomeric
ect.8,11,24
The behaviour of glycopyranosyl azides 11–13 with an axial
bstituent in position 4 was different from that of the previously
died 1,2-trans glycopyranosyl azides (1, 7–9). Contrary to other
azides, transformation of the b-D-galacto conﬁgured 11 into the
rresponding triazoles 18 needed longer reaction time. The a-L-
abinopyranosyl azide 12 provided similar results, however,
ol % catalyst load was sufﬁcient for the synthesis of 19b and
d. Results with the b-L-fucopyranosyl derivatives 20 are similar
experiences in the a-D-glycopyranosyl cases 6, 17 that is, to
hieve total consumption of the starting material 13 the catalyst
ncentration had to be increased to 2–5 mol %. These observa-
ns are in line with literature experiences where b-D-manno
d b-D-galacto conﬁgured glycopyranosyl azides with axial sub-






 ii) C3H7COOCu(PPh3)2, CH2Cl2, rt 
Conditions
i ii
eld (%) Catalyst (mol %) Reaction timeb Yield (%)
2 1 day 90
t investigated 1 1 h 96
1 1 h 92
1 10 min 95
reaction 5 1 day 89
t investigated 1 8 h 97
c 1 4 h 90
reaction 1 4 h 92
8 1 day Tracesd
t investigated 2 5 h 87
2 1 day 91
5 1 day 76e
for 5 and 6 were used.24oi:10.1016/j.carres.2012.01.004
and/or in lower yields as compared to the b-D-glucopyranosyl
counterparts.13,17
3. Conclusion
Application of the C3H7COOCu(PPh3)2 complex as a highly active
catalyst in CuAAC reactions with a variety of glycosyl azides gave
150 the corresponding 1,2,3-triazoles in excellent yields. The presence
of a free hydroxyl group in the alkyne, increasing steric hindrance
or diminished reactivity as well as the presence of an axial substitu-
ent in the pyranoid ring of the glycosyl azide required higher cata-
lyst load and/or extended reaction times. Generally, this catalyst
has broader applicability with glycosyl azides than the commonly
used CuSO4/L-ascorbic acid system.
4. Experimental
4.1. General methods
Melting points were measured in open capillary tubes or on a
160 Koﬂer hot-stage and are uncorrected. Optical rotations were deter-
mined with a Perkin–Elmer 241 polarimeter at rt. NMR spectra
were recorded with Bruker 360 (360/90 MHz for 1H/13C) spectrom-
eter. Chemical shifts are referenced to Me4Si (1H), or to the residual
solvent signals (13C). TLC was performed on DC-Alurolle Kieselgel
60 F254 (Merck), and the plates were visualised under UV light
and by gentle heating. For column chromatography Kieselgel 60
(Merck, particle size 0.063–0.200 mm) was used. Dichloromethane
was distiled from P4O10 and stored over 4 Å molecular sieves. Prop-
argyl alcohol (a), propargyl acetate (b), ethyl propiolate (c) and
170 phenylacetylene (d) were purchased from Aldrich. 2-Ethynylnaph-
thalene30 (e) and the per-O-acylated glycopyranosyl azides31–35
1–3 and 7–13 as well as the complex29 C3H7COOCu(PPh3)2 were
synthesized according to published procedures.
4.2. General procedure for the synthesis of peracylated 1-glyco




















From 1 (0.1 g, 0.27 mmol), ethyl propiolate (28 lL, 0.27 mmol)
and C3H7COOCu(PPh3)2 (1.8 mg, 2.7 lmol) according to Section
4.2. Puriﬁed by column chromatography (2:3 EtOAc–hexane) to
yield 0.12 g (92%) of white solid. 1H and 13C NMR data correspond
to the reported spectra.24
4.2.4. 4-Phenyl-1-(20,30,40,60-tetra-O-acetyl-b-D-glucopyranosyl)-
1,2,3-triazole (4d)
From 1 (0.1 g, 0.27 mmol), phenylacetylene (29 lL, 0.27 mmol)
and C3H7COOCu(PPh3)2 (1.8 mg, 2.7 lmol) according to Section 4.2.
210Puriﬁed by column chromatography (2:3 EtOAc–hexane) to yield




From 2 (0.1 g, 0.15 mmol), propargyl alcohol (9 lL, 0.15 mmol)
and C3H7COOCu(PPh3)2 (5.1 mg, 7.6 lmol) according to Section
4.2. Puriﬁed by column chromatography (2:1 EtOAc–hexane) to
yield 0.10 g (89%) of white solid. 1H and 13C NMR data correspond
to the reported spectra.24
2204.2.6. [4-Acetoxymethyl-1-(30,40,50,70-tetra-O-benzoyl-b-D-gluco-
hept-2-ulopyranosyl)-1,2,3-triazole]onamide (5b)
From 2 (0.1 g, 0.15 mmol), propargyl acetate (15 lL, 0.15 mmol)
and C3H7COOCu(PPh3)2 (1.0 mg, 1.5 lmol) according to Section 4.2.
Puriﬁed by column chromatography (1:1 EtOAc–hexane) to yield
0.11 g (97%) of colourless oil. Rf: 0.51 (5:4 EtOAc–hexane); [a]D
9 (c 0.56, CHCl3); 1H NMR (CDCl3): d (ppm) 8.10–7.23 (21H, m,
aromatics, triazole CH), 6.97 (1H, s, CONH2), 6.56 (1H, s, CONH2),
6.33 (1H, pseudo t, J = 8.0, 8.0 Hz, H-40 or H-50), 6.17 (1H, d,
J = 8.0 Hz, H-30), 5.89 (1H, pseudo t, J = 9.2, 8.6 Hz, H-40 or H-50),
2305.23 (1H, ddd, J = 9.9, 3.7, <1 Hz, H-60), 5.10 (2H, s, CH2), 4.89
(1H, dd, J = 12.3, <1 Hz, H-70a), 4.57 (1H, dd, J = 12.3, 3.7 Hz, H-
70b), 2.00 (3H, s, CH3); 13C NMR (CDCl3): d (ppm) 170.5, 166.2,
166.1, 165.0, 164.9, 164.2 (CO), 142.9 (triazole C-4), 133.7–128.2
(aromatics), 122.5 (triazole C-5), 89.4 (C-20), 73.9, 72.2, 71.0, 68.1
(C-30–C-60), 62.3 (C-70), 57.1 (CH2), 20.6 (CH3). Anal. Calcd for
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kyne (a–e) were dissolved in anhydrous CH2Cl2 (2 mL), C3H7COOC
u(PPh3)2 (1–5 mol %, Tables 1 and 2) catalyst was added, th
mixture was stirred at rt and monitored by TLC (1:1 EtOAc–hex
ane). After completion of the reaction (Tables 1 and 2), the solven




From 1 (0.1 g, 0.27 mmol), propargyl alcohol (16 lL, 0.27 mmo
and C3H7COOCu(PPh3)2 (3.6 mg, 5.4 lmol) according to Section 4.2
Puriﬁed by column chromatography (2:1 EtOAc–hexane) to yiel




From 1 (0.1 g, 0.27 mmol), propargyl acetate (27 lL, 0.27 mmo
and C3H7COOCu(PPh3)2 (1.8 mg, 2.7 lmol) according to Section 4.2
Puriﬁed by column chromatography (1:1 EtOAc–hexane) to yiel
0.12 g (96%) of white solid. Mp: 151–153 C (lit.8 mp: 143–144 C
[a]D 24 (c 0.57, CHCl3); 1H and 13C NMR data correspond to th
reported spectra.8Please cite this article in press as: Bokor, É.; et al. Carbohydr. Res. (20H, 4.63; N, 7.24.
4.2.7. [4-Ethoxycarbonyl-1-(30,40,50,70-tetra-O-benzoyl-b-D-
gluco-hept-2-ulopyranosyl)-1,2,3-triazole]onamide (5c)
From 2 (0.1 g, 0.15 mmol), ethyl propiolate (15 lL, 0.15 mmo
and C3H7COOCu(PPh3)2 (1.0 mg, 1.5 lmol) according to Sectio
4.2. Puriﬁed by column chromatography (2:3 EtOAc–hexane) t
yield 0.10 g (90%) of colourless oil.1H and 13C NMR data correspon
to the reported spectra.24
4.2.8. [4-Phenyl-1-(30,40,50,70-tetra-O-benzoyl-b-D-gluco-hept-2-
ulopyranosyl)-1,2,3-triazole]onamide (5d)
From 2 (0.1 g, 0.15 mmol), phenylacetylene (17 lL, 0.15 mmo
and C3H7COOCu(PPh3)2 (1.0, 1.5 lmol) according to Section 4.2
Puriﬁed by column chromatography (2:3 EtOAc–hexane) to yiel




From 3 (0.1 g, 0.27 mmol), propargyl acetate (27 lL, 0.27 mmo
and C3H7COOCu(PPh3)2 (3.6 mg, 5.4 lmol) according to Section 4.2
Puriﬁed by column chromatography (1:1 EtOAc–hexane) to yiel
0.11 g (87%) of white solid. Mp: 139–141 C; [a]D +92 (c 0.51
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PlH, d, J = 6.2 Hz, H-10), 6.25 (1H, pseudo t, J = 9.9, 9.2 Hz, H-30 or H-
, 5.33 (1H, dd, J = 9.9, 6.2 Hz, H-20), 5.27–5.21 (3H, m, H-30 or H-
CH2), 4.39 (1H, ddd, J = 10.5, 3.7, <1 Hz, H-50), 4.27 (1H, dd,
12.3, 3.7 Hz, H-60a), 4.04 (1H, dd, J = 12.3, <1 Hz, H-60b), 2.10,
7 (2), 2.04, 1.88 (5  3H, 5s, OCOCH3); 13C NMR (CDCl3): d
pm) 170.6, 170.3, 170.0, 169.5 (2) (COCH3), 142.4 (triazole C-4),
5.8 (triazole C-5), 81.3 (C-10), 71.1, 70.2, 69.6, 67.8 (C-20–C-50),
.1 (C-60), 57.2 (CH2), 20.7, 20.5 (3), 20.1 (COCH3). Anal. Calcd
r C19H25N3O11 (471.42): C, 48.41; H, 5.35; N, 8.91. Found: C,
.56; H, 5.44; N, 8.78.
.10. Ethyl 1-(20,30,40,60-tetra-O-acetyl-a-D-glucopyranosyl)-
,3-triazole-4-carboxylate (6c)
From 3 (0.1 g, 0.27 mmol), ethyl propiolate (28 lL, 0.27 mmol)
d C3H7COOCu(PPh3)2 (3.6 mg, 5.4lmol) according to Section
. Puriﬁed by column chromatography (4:5 EtOAc–hexane) to




From 3 (0.1 g, 0.27 mmol), phenylacetylene (29 lL, 0.27 mmol)
d C3H7COOCu(PPh3)2 (9 mg, 14 lmol) according to Section 4.2.




















































Reported yield by a different method: 90%.12




From 7 (0.1 g, 0.33 mmol), propargyl acetate (33 lL, 0.33 mmol)








duct Catalyst (mol %) Reaction time Yield (%)
b 1 2 h 96
d 1 10 min 93
e 1 10 min 86
b 1 1 h 88
d 1 30 min 94a
e 1 30 min 85
d 1 10 min 99
e 2 6 h 96
d 5 1 day 98
b 1 6 h 92
d 2 8 h 90b
b 1 2 h 96
d 1 5 h 98
b 2 4 h 96
d 5 2 h 973 g (96%) of white solid. Mp: 160–161 C; [a]D 55 (c 0.50,
Cl3); 1H NMR (CDCl3): d (ppm) 7.87 (1H, s, triazole CH), 5.83
H, d, J = 8.0 Hz, H-10), 5.47–5.38 (2H, m, H-20, H-30), 5.25–5.14
H, m, H-40, CH2), 4.31 (1H, dd, J = 11.1, 5.5 Hz, H-50a), 3.64 (1H,
eudo t, J = 11.1, 11.1 Hz, H-50b), 2.08 (2), 2.06, 1.89 (4  3H, 4s,
OCH3); 13C NMR (CDCl3): d (ppm) 170.6, 169.7, 169.6, 168.8
COCH3), 143.5 (triazole C-4), 122.0 (triazole C-5), 86.1 (C-10),
.9, 70.4, 68.2 (C-20–C-40), 65.4 (C-50), 57.3 (CH2), 20.6, 20.5,
.4, 20.0 (OCOCH3). Anal. Calcd for C16H21N3O9 (399.35): C,
.12; H, 5.30; N, 10.52. Found: C, 48.24; H, 5.17; N, 11.02.
.13. 4-Phenyl-1-(20,30,40-tri-O-acetyl-b-D-xylopyranosyl)-
,3-triazole (14d)
From 7 (0.2 g, 0.66 mmol), phenylacetylene (73 lL, 0.66 mmol)
d C3H7COOCu(PPh3)2 (4.5 mg, 6.6 lmol) according to Section 4.2.












































































































É. Bokor et al. / Carbohydrate Research xxx (2012) xxx–xxx 5
CAR 6051 No. of Pages 8, Model 5G
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(DMSO-d6): d (ppm) 8.95 (1H, s, triazole CH), 7.84–7.34 (5H, m
aromatics), 6.29 (1H, d, J = 8.6 Hz, H-10), 5.64, 5.56 (2  1H, 2 pseu
do t, J = 9.2, 9.2 Hz in each, H-20, H-30), 5.12 (1H, ddd, J = 10.5, 9.2
5.5 Hz, H-40), 4.13 (1H, dd, J = 11.1, 5.5 Hz, H-50a), 3.90 (1H, pseud
t, J = 11.1, 10.5 Hz, H-50b), 2.03, 2.01, 1.81 (3  3H, 3s, OCOCH3); 13
NMR (DMSO-d6): d (ppm) 169.5 (2), 168.6 (OCOCH3), 146.8 (tria
zole C-4), 130.1, 129.0 (2), 128.2, 125.1 (2) (aromatics), 120.2 (tr
azole C-5), 84.7 (C-10), 71.7, 70.4, 68.0 (C-20–C-40), 64.0 (C-50), 20.4
20.3, 19.9 (OCOCH3). Anal. Calcd for C19H21N3O7 (403.39): C, 56.57
H, 5.25; N, 10.42. Found: C, 56.44; H, 5.37; N, 10.30.
4.2.14. 4-(2-Naphthyl)-1-(20,30,40-tri-O-acetyl-b-D-xylopyranosy
-1,2,3-triazole (14e)
From 7 (0.1 g, 0.33 mmol), 2-ethynylnaphthalene (0.05
0.33 mmol) and C3H7COOCu(PPh3)2 (2.2 mg, 3.3 lmol) accordin
to Section 4.2. Puriﬁed by recrystallisation from EtOH to yiel
0.13 g (86%) of white solid. Mp: 285–286 C; 1H NMR (DMSO-d6
d (ppm) 9.08 (1H, s, triazole CH), 8.41–7.54 (7H, m, aromatics
6.33 (1H, d, J = 8.6 Hz, H-10), 5.67, 5.58 (2  1H, 2 pseudo
J = 9.2, 9.2 Hz in each, H-20, H-30), 5.14 (1H, ddd, J = 10.5, 9.2
4.9 Hz, H-40), 4.15 (1H, dd, J = 11.1, 4.9 Hz, H-50a), 3.92 (1H, pseud
t, J = 11.1, 10.5 Hz, H-50b), 2.05, 2.02, 1.83 (3  3H, 3s, OCOCH3); 13
NMR (DMSO-d6): d (ppm) 169.5 (2), 168.6 (OCOCH3), 146.8 (tria
zole C-4), 132.9, 132.6, 128.6, 127.9, 127.6, 127.5, 126.6, 126.2
123.6, 123.4 (aromatics), 120.5 (triazole C-5), 84.7 (C-10), 71.7
70.4, 67.9 (C-20–C-40), 64.0 (C-50), 20.4, 20.2, 19.8 (OCOCH3). Ana
Calcd for C23H23N3O7 (453.44): C, 60.92; H, 5.11; N, 9.27. Found
C, 61.01; H, 5.25; N, 9.18.
4.2.15. 1-(20-Acetamido-20-deoxy-30,40,60-tri-O-acetyl-b-D-gluco
pyranosyl)-4-acetoxy-methyl-1,2,3-triazole (15b)
From 8 (0.2 g, 0.54 mmol), propargyl acetate (53 lL, 0.54 mmo
and C3H7COOCu(PPh3)2 (3.6 mg, 5.4 lmol) according to Section 4.2
Puriﬁed by column chromatography (4:1 EtOAc–hexane, the
EtOAc) to yield 0.22 g (88%) of white solid. Mp: 240–241 C; [a]
30 (c 0.51, CHCl3); 1H NMR (CDCl3): d (ppm) 7.98 (1H, s, triazol
CH), 6.75 (1H, d, J = 8.8 Hz, NHAc), 6.15 (1H, d, J = 9.6 Hz, H-10
5.55 (1H, pseudo t, J = 9.6, 9.6 Hz, H-30or H-40), 5.27–5.22 (3H, m
H-30or H-40, CH2) 4.61 (1H, ddd, J = 9.6, 9.6, 8.7 Hz H-20), 4.30 (1H
dd, J = 12.3, 4.4 Hz, H-60a), 4.16 (1H, dd, J = 12.3, <1 Hz, H-60b
4.09 (1H, ddd, J = 8.8, 4.4, <1 Hz, H-50), 2.07 (12H, s, 4  OCOCH3
1.77 (3H, s, NHCOCH3); 13C NMR (CDCl3): d (ppm) 170.6 (4
169.3, (COCH3), 143.2 (triazole C-4), 123.0 (triazole C-5), 85.7 (C
10), 74.8, 72.1, 68.0 (C-30–C-50), 61.7 (C-60), 57.3 (CH2), 53.3 (C-20
22.7, 20.8, 20.6, 20.5 (2) (COCH3). Anal. Calcd for C19H26N4O1




From 8 (0.1 g, 0.27 mmol), phenylacetylene (29 lL, 0.27 mmo
and C3H7COOCu(PPh3)2 (1.8 mg, 2.7 lmol) according to Section 4.2
Puriﬁed by column chromatography (7:3 EtOAc–hexane, the
MeOH) to yield 0.12 g (94%) of white solid. Mp: 282–284 C; [a]




From 8 (0.2 g, 0.54 mmol), 2-ethynylnaphthalene (0.08
0.54 mmol) and C3H7COOCu(PPh3)2 (3.6 mg, 5.4 lmol) accordin
to Section 4.2. Puriﬁed by column chromatography (7:3 EtOAc
hexane, then MeOH) to yield 0.24 g (85%) of white solid. Mp
298–300 C; [a]D 70 (c 0.51, DMSO); 1H NMR (DMSO-d6):
(ppm) 9.00 (1H, s, triazole CH), 8.42 (1H, s, aromatic), 8.17–7.5Please cite this article in press as: Bokor, É.; et al. Carbohydr. Res. (20(7H, m, aromatics, NHAc), 6.19 (1H, d, J = 9.6 Hz, H-10), 5.42, 5.1
(2  1H, 2 pseudo t, J = 9.6 Hz in each, H-30, H-40), 4.69 (1H, ddd
J = 9.6, 9.6, 8.8 Hz, H-20), 4.31 (1H, ddd, J = 8.8, 4.4, <1 Hz, H-50
4.20 (1H, dd, J = 12.3, 4.4 Hz, H-60a), 4.10 (1H, dd, J = 12.3, <1 H
H-60b), 2.03, 2.01, 1.97 (3  3H, 3s, OCOCH3), 1.60 (3H, s, NHCOCH3
13C NMR (DMSO-d6): d (ppm) 170.0, 169.6 169.5, 169.4, (COCH3
146.5 (triazole C-4), 133.0, 132.6, 128.6, 128.0, 127.7, 127.6
126.7, 126.3, 123.6, 123.4 (aromatics), 120.6 (triazole C-5), 84.
(C-10), 73.3, 72.2, 68.0 (C-30–C-50), 61.7 (C-60), 52.3 (C-20), 22.3
20.5, 20.4, 20.3 (COCH3). Anal. Calcd for C26H28N4O8 (524.52): C
59.54; H, 5.38; N, 10.68. Found: C, 59.70; H, 5.29; N, 10.81.
4.2.18. 1-(20-Deoxy-20-phtalimido-30,40,60-tri-O-acetyl-b-D-
glucopyranosyl)-4-phenyl-1,2,3-triazole (16d)
From 9 (0.3 g, 0.65 mmol), phenylacetylene (71 lL, 0.65 mmo
and C3H7COOCu(PPh3)2 (4.4 mg, 6.5 lmol) according to Sectio
4.2. Puriﬁed by column chromatography (2:3 EtOAc–hexane) t
yield 0.37 g (99%) of white solid. Mp: 194–196 C; [a]D 107 (
0.55, CHCl3); 1H NMR (CDCl3): d (ppm) 8.05 (1H, s, triazole CH
7.83–7.28 (9H, m, aromatics, Pht), 6.85 (1H, d, J = 10.5 Hz, H-10
6.06 (1H, J = 10.5, 9.2 Hz), 5.39 (1H, J = 9.9, 9.2 Hz), 4.94 (1H
J = 10.5, 9.9 Hz) (3 pseudo t, H-20, H-30, H-40), 4.40 (1H, dd
J = 12.3, 4.3 Hz, H-60a), 4.24–4.20 (2H, m, H-50, H-60b), 2.12, 2.09
1.89 (3  3H, 3s, OCOCH3); 13C NMR (CDCl3): d (ppm) 170.5
169.8, 169.3 (COCH3), 167.5, 166.4 (NPhtCO), 148.2 (triazole C-4
134.6, 134.4, 131.0, 130.5, 129.7, 128.7, 128.4, 125.7, 123.8 (aro
matics, Pht), 117.7 (triazole C-5), 83.0 (C-10), 75.0, 70.4, 68.1 (C
30–C-50), 61.6 (C-60), 53.9 (C-20), 20.6, 20.5, 20.3 (COCH3). Anal. Calc
for C28H26N4O9 (562.53): C, 59.78; H, 4.66; N, 9.96. Found: C, 59.89
H, 4.81; N, 9.90.
4.2.19. 1-(20-Deoxy-20-phtalimido-30,40,60-tri-O-acetyl-b-D-gluco
pyranosyl)-4-(2-naphthyl)-1,2,3-triazole (16e)
From 9 (0.3 g, 0.65 mmol), 2-ethynylnaphthalene (0.1
0.65 mmol) and C3H7COOCu(PPh3)2 (8.8 mg, 6.5 lmol) accordin
to Section 4.2. Puriﬁed by column chromatography (2:3 EtOAc
hexane) to yield 0.38 g (96%) of white solid. Mp: 194–196 C; [a]
164 (c 0.54, CHCl3); 1H NMR (CDCl3): d (ppm) 8.30–7.45 (12H
m, aromatics, Pht, triazole CH), 6.88 (1H, d, J = 10.5 Hz, H-10), 6.0
(1H, J = 10.5, 9.2 Hz), 5.40 (1H, J = 9.9, 9.2 Hz), 4.97 (1H, J = 10.5
9.9 Hz) (3 pseudo t, H-20, H-30, H-40), 4.42 (1H, dd, J = 12.3, 4.9 H
H-60a), 4.26–4.21 (2H, m, H-50, H-60b), 2.13, 2.10, 1.90 (3  3H, 3
OCOCH3); 13C NMR (CDCl3): d (ppm) 170.5, 169.9, 169.4 (COCH3
167.6, 166.5 (NPhtCO), 148.3 (triazole C-4), 134.6–123.8 (aroma
ics, Pht), 118.0 (triazole C-5), 83.1 (C-10), 75.1, 70.4, 68.2 (C-30–C
50), 61.6 (C-60), 54.0 (C-20), 20.7, 20.6, 20.3 (COCH3). Anal. Calcd fo
C32H28N4O9 (612.59): C, 62.74; H, 4.61; N, 9.15. Found: C, 62.60
H, 4.70; N, 9.04.
4.2.20. 1-(20-Deoxy-20-phtalimido-30,40,60-tri-O-acetyl-a-D-gluco
pyranosyl)-4-phenyl-1,2,3-triazole (17d)
From 10 (0.1 g, 0.22 mmol), phenylacetylene (24 lL, 0.22 mmo
and C3H7COOCu(PPh3)2 (7.3 mg, 11 lmol) according to Section 4.2
Puriﬁed by column chromatography (4:5 EtOAc–hexane) to yiel
0.12 g (98%) of white solid. Mp: 161–163 C; [a]D +182 (c 0.54
CHCl3); 1H NMR (CDCl3): d (ppm) 7.91 (1H, s, triazole CH), 7.79
7.29 (9H, m, aromatics, Pht), 7.17 (1H, pseudo t, J = 10.5, 10.5 H
H-30), 6.44 (1H, d, J = 5.5 Hz, H-10), 5.30 (1H, pseudo t, J = 9.9
9.2 Hz, H-40), 5.07 (1H, dd, J = 10.5, 5.5 Hz, H-20), 4.70 (1H, ddd
J = 10.5, 3.1, <1 Hz, H-50), 4.37 (1H, dd, J = 12.3, 3.1 Hz, H-60a), 4.1
(1H, dd, J = 12.3, <1 Hz, H-60b), 2.10, 1.90 (9H, 2s, 3  OCOCH3
13C NMR (CDCl3): d (ppm) 170.4, 170.1, 168.9 (COCH3), 166.8 (2
(NPhtCO), 147.3 (triazole C-4), 134.5 (2), 130.7 (2), 129.6, 128.
(2), 128.4, 125.8 (2), 123.7 (2) (aromatics, Pht), 121.0 (triazole C




































































69.6, 67.8 (C-2 –C-5 ), 57.1 (CH2), 20.5, 20.3, 20.2, 19.9 (OCOCH3),
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Pl.6 (3) (COCH3). Anal. Calcd for C28H26N4O9 (562.53): C, 59.78; H,
6; N, 9.96. Found: C, 59.68; H, 4.77; N, 10.05.
.21. 4-Acetoxymethyl-1-(20,30,40,60-tetra-O-acetyl-b-D-galac
pyranosyl)-1,2,3-triazole (18b)
From 11 (0.1 g, 0.27 mmol), propargyl acetate (27 lL, 0.27 mmol)
d C3H7COOCu(PPh3)2 (1.8 mg, 2.7 lmol) according to Section 4.2.
riﬁed by column chromatography (1:1 EtOAc–hexane) to yield
2 g (92%) of white solid. Mp: 110–112 C; [a]D 7 (c 0.50, CHCl3);
NMR (CDCl3): d (ppm) 7.93 (1H, s, triazole CH), 5.92 (1H, d,
9.2 Hz, H-10), 5.57–5.52 (2H, m, H-20, H-40), 5.33–5.19 (3H, m, H-
CH2), 4.32 (1H, pseudo t, J = 6.2, 6.2, H-50), 4.25–4.13 (2H, m, H-
, H-60b), 2.24, 2.10, 2.05, 2.02, 1.89 (5  3H, 5s, OCOCH3); 13C
R (CDCl3): d (ppm) 170.6, 170.1, 169.8, 169.6, 168.8 (OCOCH3),
3.3 (triazole C-4), 122.1 (triazole C-5), 85.9 (C-10), 73.8, 70.5, 67.7,
.7 (C-20–C-50), 61.1 (C-60), 57.2 (CH2), 20.6, 20.4 (2), 20.3, 20.0
COCH3). Anal. Calcd for C19H25N3O11 (471.42): C, 48.41; H, 5.35; N,
1. Found: C, 48.52; H, 5.26; N, 8.78.
.22. 4-Phenyl-1-(20,30,40,60-tetra-O-acetyl-b-D-galactopyran
yl)-1,2,3-triazole (18d)
From 11 (0.1 g, 0.27 mmol), phenylacetylene (29 lL, 0.27 mmol)
d C3H7COOCu(PPh3)2 (3.6 mg, 5.4 lmol) according to Section 4.2.
riﬁed by column chromatography (4:5 EtOAc–hexane) to yield
2 g (90%) of white solid. Mp: 197–199 C (lit.19 mp: 197–




From 12 (0.1 g, 0.33 mmol), propargyl acetate (33 lL,
3 mmol) and C3H7COOCu(PPh3)2 (2.2 mg, 3.3 lmol) according
Section 4.2. Puriﬁed by column chromatography (1:1 EtOAc–hex-
e) to yield 0.13 g (96%) of white solid. Mp: 183–184 C; [a]D +2 (c
0, CHCl3); 1H NMR (CDCl3): d (ppm) 7.93 (1H, s, triazole CH), 5.81
H, d, J = 9.2 Hz, H-10), 5.58 (1H, pseudo t, J = 9.9, 9.2 Hz, H-20), 5.45
H, br s, H-40), 5.29 (1H, dd, J = 9.9, 3.1 Hz, H-30), 5.21, 5.19 (2  1H,
, J = 12.9 Hz in each, CH2a, CH2b), 4.20(1H, d, J = 13.6 Hz, H-50a),
0 (1H, d, J = 13.6 Hz, H-50b), 2.23, 2.09, 2.04, 1.90 (4  3H, 4s,
OCH3); 13C NMR (CDCl3): d (ppm) 170.6, 169.9, 169.6, 168.8
COCH3), 143.3 (triazole C-4), 122.1 (triazole C-5), 86.4 (C-10),
.2, 68.0, 67.5 (C-20–C-40), 67.1 (C-50), 57.2 (CH2), 20.7, 20.6, 20.3,
.0 (OCOCH3). Anal. Calcd for C16H21N3O9 (399.35): C, 48.12; H,
0; N, 10.52. Found: C, 48.17; H, 5.46; N, 10.41.
.24. 4-Phenyl-1-(20,30,40-tri-O-acetyl-a-L-arabinopyranosyl)-
,3-triazole (19d)
From 12 (0.1 g, 0.33 mmol), phenylacetylene (37 lL, 0.33 mmol)
d C3H7COOCu(PPh3)2 (2.2 mg, 3.3 lmol) according to Section 4.2.
riﬁed by column chromatography (2:3 EtOAc–hexane) to yield
3 g (98%) of white solid. Mp: 217–219 C; [a]D 55 (c 0.51,
Cl3); 1H NMR (CDCl3): d (ppm) 8.07 (1H, s, triazole CH), 7.87–
3 (5H, m, aromatics), 5.83 (1H, d, J = 9.2 Hz, H-10), 5.68 (1H,
eudo t, J = 9.9, 9.2 Hz, H-20), 5.47 (1H, br s, H-40), 5.29 (1H, dd,
9.9, 2.5 Hz, H-30), 4.20 (1H, d, J = 13.6 Hz, H-50a), 3.99 (1H, d,
13.6 Hz, H-50b), 2.24, 2.04, 1.90 (3  3H, 3s, OCOCH3); 13C
R (CDCl3): d (ppm) 170.0, 169.8, 169.1 (OCOCH3), 148.2 (tria-
le C-4), 130.0, 128.8 (2), 128.4, 125.8 (2) (aromatics), 117.7 (tri-
ole C-5), 86.6 (C-10), 70.5, 68.0, 67.7 (C-20–C-40), 67.2 (C-50), 20.9,
.5, 20.2 (OCOCH3). Anal. Calcd for C19H21N3O7 (403.39): C, 56.57;
5.25; N, 10.42. Found: C, 56.64; H, 5.11; N, 10.27.
.25. 4-Acetoxymethyl-1-(20,30,40-tri-O-acetyl-b-L-fucopyrano
l)-1,2,3-triazole (20b)
From 13 (0.1 g, 0.32 mmol), propargyl acetate (32 lL,











































ease cite this article in press as: Bokor, É.; et al. Carbohydr. Res. (2012), dSection 4.2. Puriﬁed by column chromatography (1:1 EtOAc–
xane) to yield 0.13 g (96%) of colourless oil. Rf: 0.37 (1:1
OAc–hexane); [a]D +13 (c 0.52, CHCl3); 1H NMR (CDCl3): d
pm) 7.94 (1H, s, triazole CH), 5.89 (1H, d, J = 9.2 Hz, H-10), 5.52
H, pseudo t, J = 9.9, 9.9 Hz, H-20), 5.42 (1H, d, J = 2.5 Hz, H-40),
2 (1H, dd, J = 9.9, 2.5 Hz, H-30), 5.25, 5.20 (2  1H, 2d,
12.9 Hz in each, CH2a, CH2b), 4.20 (1H, q, J = 6.2 Hz, H-50), 2.26,
9, 2.02, 1.89 (4  3H, 4s, OCOCH3), 1.28 (3H, d, J = 6.2 Hz, CH3);
NMR (CDCl3): d (ppm) 170.4, 170.1, 169.5, 168.8 (OCOCH3),
3.0 (triazole C-4), 122.0 (triazole C-5), 85.9 (C-10), 72.3, 70.8,
0 0.7 (CH3). Anal. Calcd for C17H23N3O9 (413.38): C, 49.39; H, 5.61;
50010.17. Found: C, 49.32; H, 5.75; N, 10.11.
.26. 4-Phenyl-1-(20,30,40-tri-O-acetyl-b-L-fucopyranosyl)-
,3-triazole (20d)
From 13 (0.1 g, 0.32 mmol), phenylacetylene (35 lL,
2 mmol) and C3H7COOCu(PPh3)2 (10.7 mg, 16 lmol) according
Section 4.2. Puriﬁed by column chromatography (2:3 EtOAc–
xane) to yield 0.13 g (97%) of white solid. Mp: 237–239 C;
]D +67 (c 0.51, CHCl3); 1H NMR (CDCl3): d (ppm) 8.08 (1H, s, tri-
ole CH), 7.87–7.29 (5H, m, aromatics), 5.89 (1H, d, J = 9.2 Hz, H-
, 5.62 (1H, pseudo t, J = 9.9, 9.9 Hz, H-20), 5.42 (1H, d, J = 2.5 Hz,
51040), 5.29 (1H, dd, J = 9.9, 2.5 Hz, H-30), 4.16 (1H, q, J = 6.2 Hz, H-
, 2.26, 2.02, 1.89 (3  3H, 3s, OCOCH3), 1.28 (3H, d, J = 6.2 Hz,
3); 13C NMR (CDCl3): d (ppm) 170.2, 169.7, 169.1 (OCOCH3),
8.1 (triazole C-4), 130.0, 128.7 (2), 128.3, 125.8 (2) (aromatics),
7.7 (triazole C-5), 86.2 (C-10), 72.6, 71.1, 69.8, 67.8 (C-20–C-50),
.6, 20.4, 20.2 (OCOCH3), 15.9 (CH3). Anal. Calcd for C20H23N3O7
17.41): C, 57.55; H, 5.55; N, 10.07. Found: C, 57.64; H, 5.69; N,
8.
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